We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Smartphone Case Offers Glucose Monitoring Regardless of Location

By LabMedica International staff writers
Posted on 20 Dec 2017
Currently, checking blood sugar levels can be a hassle for people with diabetes, especially when they have to pack their glucose monitoring kits around with them every time they leave the house.

A smartphone case and application have been developed that could make it easier for patients to record and track their blood glucose readings, whether they are at home or on the go. More...
In a proof of concept study the new smartphone-based can be used as a reusable glucose meter.

Bioengineers at the University of California - San Diego (La Jolla, CA, USA) have developed a glucose meter that includes a custom-built smartphone case that houses a permanent bare sensor strip, a stylus that is loaded with enzyme-carbon composite pellets, and sensor instrumentation circuits. A custom-designed Android-based software application was developed to enable easy and clear display of measured glucose concentration.

The device called a GPhone and a typical test involves the user loading the software, using the stylus to dispense an enzymatic pellet on top of the bare sensor strip affixed to the case, and then introducing the sample. The electronic module then acquires and via Bluetooth wirelessly transmits the data to the application software to be displayed on the screen. The deployed pellet is then discarded to regain the fresh bare sensor surface.. The stylus holds enough pellets for 30 tests before it needs to be refilled. A printed circuit board enables the whole system to run off a smartphone battery.

The pellets contain an enzyme called glucose oxidase that reacts with glucose. This reaction generates an electrical signal that can be measured by the sensor's electrodes. The greater the signal, the higher the glucose concentration. The team tested the system on different solutions of known glucose concentrations. The test takes about 20 seconds and the results were accurate throughout multiple tests. The study revealed that the enzyme loaded in the pellets are stable for up to eight months at ambient conditions, and generate reproducible sensor signals.

Joseph Wang, DSc, a professor of Nanoengineering and a senior author of the study, said, “This system is versatile and can be easily modified to detect other substances for use in healthcare, environmental and defense applications.” The study was originally published online on October 17, 2017, in the journal Biosensors and Bioelectronics.

Related Links:
University of California - San Diego


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test Identifies Early Breast and Prostate Cancer Signals Years Before Diagnosis

Breast and prostate cancers are among the most common cancers, yet many are detected only after tumors have become established. Identifying disease earlier could support closer monitoring and help distinguish... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Microbiology

view channel
Image: Graphical Abstract (Andrew Medina-Marino, Chibuzor M Babalola, Mandisa M Mdingi, et al. Clinical Infectious Diseases, 2026. doi:10.1093/cid/ciag577.)

Repeat Prenatal STI Screening and Treatment May Reduce Preterm Births

Preterm birth remains a major obstetric concern and is associated with serious complications in early childhood. Common sexually transmitted infections during pregnancy often cause no symptoms, making... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.